Inclusion Criteria (main):  Healthy males or healthy, non-pregnant, non-lactating females Body weight of at least 50 kg Body mass index between ≥18.0 and ≤32.0 kg/m2 Good state of health (mentally and physically) Negative severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) test, if required and per site policy  Exclusion Criteria (main):  Have received any investigational drug in a clinical research study within the previous 30 days before screening Have received a coronavirus disease 2019 (COVID-19) vaccine within 2 weeks prior to randomization History of any drug or alcohol abuse in the past 2 years Females of childbearing potential who are pregnant or lactating or planning to become pregnant during the study Clinically significant abnormal biochemistry, hematology, coagulation, or urinalysis as judged by the investigator